|
Q3 FY2019
As of Dec 30, 2018
|
Q2 FY2019
As of Sep 30, 2018
|
Q1 FY2019
As of Jul 1, 2018
|
Q4 FY2018
As of Apr 1, 2018
|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Oct 1, 2017
|
Q1 FY2018
As of Jul 2, 2017
|
Q4 FY2017
As of Apr 2, 2017
|
Q3 FY2017
As of Jan 1, 2017
|
Q2 FY2017
As of Oct 2, 2016
|
Q1 FY2017
As of Jul 3, 2016
|
Q4 FY2016
As of Apr 3, 2016
|
Q3 FY2016
As of Jan 3, 2016
|
Q2 FY2016
As of Sep 27, 2015
|
Q1 FY2016
As of Jun 28, 2015
|
Q4 FY2015
As of Mar 29, 2015
|
Q3 FY2015
As of Dec 28, 2014
|
Q2 FY2015
As of Sep 28, 2014
|
Q1 FY2015
As of Jun 29, 2014
|
Q4 FY2014
As of Mar 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepayments and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Convertible Notes Conversion Obligation And Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and related expenses | ||||||||||||||||||||
| Deferred income on shipments to distributors | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Short-term convertible notes | ||||||||||||||||||||
| Current portion of bank loan | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Long-term income tax payable | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Long-term bank loan, net | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitments and contingencies (Note 13) | ||||||||||||||||||||
| Convertible notes conversion obligation | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock: $0.001 par value: 10,000 shares authorized; no shares issued | ||||||||||||||||||||
| Common stock: $0.001 par value: 350,000 shares authorized; 128,992 and 129,531 shares outstanding as of December 30, 2018 and April 1, 2018, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost: 131,922 and 128,518 shares as of December 30, 2018 and April 1, 2018, respectively | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities, convertible notes conversion obligation and stockholders' equity | ||||||||||||||||||||
Loading...
